Biallelic loss of function variants in SYT2 cause a treatable congenital onset presynaptic myasthenic syndrome

New publication with NMD4C lead investigator as co-author Biallelic loss of function variants in SYT2 cause a treatable congenital onset presynaptic myasthenic syndrome https://t.co/oiNSDMlNUa

Biallelic loss of function variants in SYT2 cause a treatable congenital onset presynaptic myasthenic syndrome. https://t.co/GXH0ivaUzC

Biallelic loss of function variants in SYT2 cause a treatable congenital onset presynaptic myasthenic syndrome. https://t.co/VgJwhfnLH8